Standard BioTools Inc. (FRA:FLB)

Germany flag Germany · Delayed Price · Currency is EUR
1.210
-0.010 (-0.82%)
At close: Dec 4, 2025
-33.52%
Market Cap 474.86M
Revenue (ttm) 144.67M
Net Income (ttm) -109.31M
Shares Out n/a
EPS (ttm) -0.29
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 911
Open 1.210
Previous Close 1.220
Day's Range 1.210 - 1.210
52-Week Range 0.805 - 2.060
Beta n/a
RSI 57.88
Earnings Date Feb 6, 2026

About Standard BioTools

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consumables, software, and services based upon technologies used in the identification of proteins, as well as genes and their functions. The company provide... [Read more]

Industry Laboratory Analytical Instruments
Founded 1999
Employees 818
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol FLB
Full Company Profile

Financial Performance

In 2024, Standard BioTools's revenue was $174.43 million, an increase of 64.03% compared to the previous year's $106.34 million. Losses were -$184.90 million, 147.7% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.